Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gentiva Health Services Inc raises low end of prior FY 2014 EBITDA and EPS guidance to a range above analysts' estimates; narrows FY 2014 revenue guidance


Tuesday, 5 Aug 2014 07:00am EDT 

Gentiva Health Services Inc:Says that based on its strong year-to-date operating results, Gentiva now expects FY 2014 adjusted EBITDA to be in range of $183 mln to $195 mln and adjusted income attributable to Gentiva shareholders to be in range of $0.95 to $1.15 on diluted per share (EPS) basis.Expects FY 2014 net revenues to be in range of $1.96 bln to $2.0 bln.FY 2014 EBITDA of $181 mln, EPS of $0.90 and revenue of $1.97 bln - Thomson Reuters I/B/E/S. 

Company Quote

19.05
-0.1 -0.52%
19 Dec 2014